Anti-cancer drug fights immune reaction in some infants with Pompe disease
Thursday, October 11, 2012 - 16:00
in Health & Medicine
Adding a third anti-cancer agent to a current drug cocktail appears to have contributed to dramatic improvement in three infants with the most severe form of Pompe disease -- a rare, often-fatal genetic disorder characterized by low or no production of an enzyme crucial to survival.